RNXT - RenovoRx Inc (Healthcare: Biotechnology) Projected Earnings Date: 2024-08-16    (Delayed quote data   2025-07-10)
Last
 1.34		 Change
 ⇑ +0.03   (+2.29%)		 Volume
  39,608
Open
 1.30		 High
 1.37		 Low
 1.30
8EMA (Daily)
 1.32		 40EMA (Daily)
 1.28		 50EMA (Daily)
 1.26		 STO (Daily)
 37.333		 MACD Hist (Daily)
 -0.018
8EMA (Weekly)
 1.296		 40EMA (Weekly)
 1.19		 50EMA (Weekly)
 1.21		 STO (Weekly)
 83.143		 MACD Hist (Weekly)
 0.062
Company Profile
RenovoRx Inc is a clinical-stage biopharmaceutical company. It is focused on developing therapies for the local treatment of solid tumors and conducting a Phase 3 registrational trial for lead product candidate RenovoGem.
optionchance optionchance
⇒ Home | Chart and Research | Education | About Us  

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Questions or Comments: support@optionchance.com
Copyright © 2025 OptionChance.com